In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.
about
Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunitiesMigrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.TRPV4 channels regulate tumor angiogenesis via modulation of Rho/Rho kinase pathwayRegulatory properties of statins and rho gtpases prenylation inhibitiors to stimulate melanoma immunogenicity and promote anti-melanoma immune response.Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer.
P2860
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.
@ast
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.
@en
type
label
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.
@ast
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.
@en
prefLabel
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.
@ast
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression.
@en
P2093
P2860
P50
P356
P1476
In vivo Effects in Melanoma of ROCK Inhibition-Induced FasL Overexpression
@en
P2093
Anne-Françoise Tilkin-Mariamé
Bertrand Florie
Gilles Favre
Iotefa Teiti
Isabelle Lajoie-Mazenc
P2860
P356
10.3389/FONC.2015.00156
P577
2015-07-14T00:00:00Z